We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Phage Lytic Enzyme Specifically Attacks MRSA

By HospiMedica International staff writers
Posted on 01 Jul 2015
Print article
Image: Bacteriophage attacking a bacteria (Photo courtesy of Hyglos).
Image: Bacteriophage attacking a bacteria (Photo courtesy of Hyglos).
A novel bacteriophagic protein has been designed to attack methicillin-resistant Staphylococcus aureus (MRSA) microbes and dissolve them.

Developed by researchers at the German Center for Infection Research (DZIF; Braunschweig, Germany) and Hyglos (Bernried, Germany), HY-133 is a synthesized phage protein that was characterized and recombinantly expressed for the selective decolonization of pathogenic Staphylococcus aureus in the nasal passages. Due to the highly specific action, the natural microflora is maintained, and HY-133 could therefore be used for the prophylactic treatment of nasal colonization, counteracting the spread of MRSA and thus preventing infections.

HY-133 was developed using proprietary phage-ligand technology, which exploit the principles of bacteriophage biology for diagnostic, antimicrobial, and research applications. The technology enables the production of advanced molecules for effective binding of bacteria, bacterial components, and lysis. Other applications of the molecules developed using the technology include food preservation, and decolonization of acne Propionibacterium germs and other bacterium, such as Clostridium difficile. HY 133 was presented at the BIO World Congress on Industrial Biotechnology, held during June 2015 in Montreal (Canada).

“We do like to describe it as a MRSA-killing protein, even if it sounds somewhat sensational,” said Wolfgang Mutter, PhD, MBA, of Hyglos. “In fact, all Staphylococcus aureus cells, whether resistant or not resistant, will be killed by this new active substance within a very short time. And this without the natural microflora in the nose being destroyed, nor does resistance develop.”

“A rapid detection and effective elimination of MRSA colonization in the nose prior to a hospital stay is a crucial step in combating these hospital germs,” added Prof. Karsten Becker, MD, of University Hospital Münster (Germany), a researcher at the DZIF. “The bacteria in the nose are increasingly resistant to the currently used antibiotic mupirocin and the duration of the decolonization and follow-up control is around one week. Under such circumstances, no effective MRSA prevention is possible for patients immediately in need of surgery.”

Bacteriophages recognize their host via proteins that bind to carbohydrate or protein structures on the surface of the bacteria. These phage proteins are very stable; some of them require heating at temperatures above 90 °C to destroy their three-dimensional structure. Phage proteins also have binding affinities comparable to monoclonal antibodies. Both properties provide durability in harsh environmental conditions, and allow bacteriophages to wait for the next opportunity to infect new host bacteria.

Related Links:

German Center for Infection Research
Hyglos


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Examination Table
Powerline Backrest Top

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.